News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
David Planchard: Neoadjuvant and adjuvant treatments for lung cancer to optimize patients’ survival
David Planchard
Mar 24, 2025, 09:05

David Planchard: Neoadjuvant and adjuvant treatments for lung cancer to optimize patients’ survival

David Planchard, Thoracic Oncologist and Professor at the University Paris Saclay, posted on LinkedIn:

“So many questions about neoadjuvant/adjuvant treatments (IO, TKI, ADC…) for lung cancer and the use of biomarkers (MRD, NGS, pCR…) to optimize our treatments and our patients’ survival.

Panel discussion here in NY!”

David Planchard

Read more posts featuring Lung Cancer at OncoDaily.com.

cancer cancer treatment David Planchard Lung cancer OncoDaily Oncology patient survival
Special Coverage
Science
Jun 2, 2025, 03:20
KRYSTAL-7 Phase II Trial First-Line Adagrasib Plus Pembrolizumab Delivers Durable Responses Across PD-L1 Levels in KRASG12C-Mutated NSCLC
Oncolibrary
Jun 2, 2025, 02:56
CheckMate 577 Final Results: Adjuvant Nivolumab Sustains Disease-Free Survival Benefit in Resected Esophageal and Gastroesophageal Junction Cancer
Oncolibrary
Jun 1, 2025, 18:59
SERENA-6 Trial at ASCO 2025: Camizestrant Plus CDK4/6i Improves Outcomes in HR+/HER2– Advanced Breast Cancer with ctDNA-Detected ESR1 Mutations
Blog
Jun 1, 2025, 18:25
Project Cure CRC has awarded 4 new grants - Colorectal Cancer Alliance
Blog
Jun 1, 2025, 18:09
Michael Jefford: Grateful for ASCO25’s Valuable Survivorship Session
Stories
Jun 1, 2025, 17:19
Shrenik Shah’s Story from Cancer Survivor to Global Advocate: From Silence to Stages
Insight
Jun 1, 2025, 17:02
Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney
Blog
Jun 1, 2025, 16:55
Oriol Mirallas: Early Data on SYNC-T Therapy for mCRPC Presented at ASCO 2025
Blog
Jun 1, 2025, 16:52
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Insight
Jun 1, 2025, 16:46
Shanda Blackmon: First trial of CAR-T cell cancer treatment for solid tumor response
Oncolibrary
Jun 1, 2025, 16:39
MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment
Opinion
Jun 1, 2025, 16:37
Massimo Di Maio: Overall Survival Analysis Should NOT be Adjusted for Subsequent Treatments